Agents Are the New UI. But Healthcare Still Needs the Foundation.

Most healthcare organizations aren’t ready for the agents they are buying. According to McKinsey’s 2025 healthcare survey, only 19% of organizations have reached agentic AI maturity. More than half are still in proof of concept. That gap matters because the marketing has moved well ahead of the infrastructure.

Everywhere you look, companies are promising agents that can automate workflows, coordinate care, manage prior authorization, summarize patient records, route tasks, and eliminate manual work across healthcare operations. The pitch is compelling because healthcare already runs on workflows. In theory, AI agents should fit naturally into the system.

The problem is that most healthcare organizations are trying to deploy agents on top of disconnected infrastructure, fragmented workflows, and incomplete data environments. Selecting the right AI development solutions matters less than ensuring those solutions have something reliable to connect to.

That is why so many AI initiatives stall after the demo phase.

Teams are under pressure to reduce operational overhead, improve clinician efficiency, and modernize experiences that still rely heavily on manual coordination between systems. AI agents feel like the next logical leap because they promise action, not just analysis.

But working in healthcare is not like deploying AI into a standard SaaS workflow. In healthcare, every workflow touches compliance, patient safety, interoperability, governance, and operational risk. An AI agent is only as effective as the systems, workflows, and data foundations supporting it.

That distinction matters more than most organizations realize.

Most Organizations Have a Workflow and Interoperability Problem, Not an Agent Problem

Right now, many healthcare teams are treating AI agents as the strategy itself. In reality, agents are just an interface layer. The real challenge is whether the underlying systems are mature enough to support intelligent automation in the first place.

Most organizations don’t have an agent problem. They have a workflow and interoperability problem.

That is the reason many AI pilots struggle to move into production. The issue is rarely model quality alone. It is fragmented EHR data, inconsistent terminology mapping, disconnected APIs, unclear workflow ownership, and the inability to reliably move information across systems in real time. AI exposes operational weaknesses that already existed. It just makes them impossible to ignore. This is also why the best artificial intelligence services development work in healthcare begins with infrastructure assessment, not model selection.

This pattern shows up in a specific way that many organizations miss. Teams often describe themselves as FHIR-ready and move forward on that assumption. But having a FHIR endpoint isn’t the same as having a production-ready signal. Latency, partial data, batch delays, and terminology mismatches all break agentic logic in ways that only surface under live conditions. An agent that cannot reliably access clean, contextual, real-time information becomes another layer of operational complexity.

That does not mean healthcare organizations should ignore agentic AI. Far from it. Agents will become a core part of the healthcare interface. The organizations that build the right foundation now will move faster and more safely than those that skip it. The key is understanding whether your organization is actually ready for them.

Five Parameters That Determine Whether an Agent Will Work in Production

As healthcare organizations move toward agentic AI, it’s easy to assume the technology itself is the hard part. In reality, most failures happen long before the model enters production. The challenge is usually operational readiness. Workflows are unclear. Systems are disconnected. Data is fragmented. Governance is still immature.

These five parameters are not just technical checkpoints. They are practical filters that help healthcare organizations determine whether an AI agent will create operational value or add another layer of complexity. Working through them early is what separates implementations that scale from pilots that stall.

Parameter #1: Is There a High-Friction, Repeatable Workflow Worth Automating?

Not every operational problem requires an AI agent. Some workflows are already predictable and rules-based enough to be handled with standard automation. Others are so inconsistent and fragmented that introducing an autonomous system would only amplify the chaos. The strongest use cases involve workflows with high operational friction, repetitive coordination tasks, and expensive manual overhead. The other essential condition is bounded autonomy: the organization should be able to state clearly what the agent is allowed to do, when it must escalate, and what done actually means.

Prior authorization is a clear example. According to AMA survey data, physicians complete an average of 40 prior authorizations per week, consuming the equivalent of 12 hours of physician and staff time. More than nine in ten physicians report that prior authorization negatively affects patient outcomes. Eligibility verification, claims exception handling, referral routing, and clinical inbox triage carry similar profiles: high volume, repetitive coordination, and significant manual overhead. These are the environments where intelligent orchestration creates real operational value.

But even in well-suited workflows, process clarity matters. If the organization cannot define how work moves through the system today, an AI agent won’t be able to do it reliably either. Automation doesn’t fix broken processes. It accelerates them.

Parameter #2: Is Your Data Environment Actually Ready?

This is where many healthcare organizations hit a wall. AI agents depend on context. They need access to structured, normalized, connected information that can move consistently between systems. Unfortunately, healthcare data environments are still filled with fragmentation, and effective AI data analysis requires a level of data quality and consistency that most organizations haven’t yet reached.

Many organizations continue to operate across a mix of HL7 v2 feeds, custom integrations, siloed EHR environments, PDFs, spreadsheets, local terminology standards, and partially implemented FHIR APIs. Even teams that describe themselves as “FHIR-ready” often discover that data quality, latency, and workflow integration issues prevent reliable automation at scale.

That creates a serious problem for agentic systems. An AI agent operating without a complete, accurate context doesn’t just produce wrong answers. It produces wrong answers with confidence. If users can’t trust the underlying data, they stop trusting the outputs. Once trust erodes, adoption follows quickly behind it.

This is why interoperability isn’t a prerequisite that organizations check off before the real work begins. It is the work. Organizations often think they need a better model when what they actually need is a better data foundation.

Parameter #3: Does the Agent Have Real Access to the Systems Where Work Happens?

Workflow embedding isn’t just a user experience consideration. It is an operational requirement. An agent that can only suggest actions in a disconnected layer isn’t replacing friction. It is adding a review step. For an agent to actually move work forward, it needs read and write access into the EHR, PMS, payer platform, or contact-center workflow where decisions are made, and actions are taken.

Healthcare teams don’t want another dashboard. They want fewer interruptions.

The most effective AI systems are embedded directly into operational workflows. They surface the right information at the moment decisions are being made. They reduce clicks instead of adding them. That requires asking concrete questions: Can the agent read the required context in real time? Can it write back safely into the relevant system? Are FHIR and HL7 mappings complete enough for the use case, or will terminology gaps and batch delays break the logic? These are the integration questions that mature machine learning development services address before deployment, not after.

This is where interoperability maturity becomes a direct performance constraint. Organizations still operating through disconnected portals or lightly embedded tools will find that agents create inconsistent experiences and require manual corrections that offset the efficiency gains. Tighter integration through SMART on FHIR, event-driven architectures, and workflow orchestration layers is what separates agents that work in production from agents that work in demos.

Parameter #4: Can You Govern and Audit the Agent’s Actions?

This is the area that most clearly separates healthcare AI from generic enterprise AI. Governance in healthcare isn’t a best practice. It’s a compliance requirement.

An AI agent that schedules appointments incorrectly is frustrating. An AI agent that introduces risk into a clinical workflow, creates inaccurate documentation, mishandles patient context, or influences care decisions without appropriate oversight creates an entirely different category of problem.

The regulatory stakes are specific. HIPAA’s minimum necessary standard requires that any system accessing protected health information limit that access to what is actually needed for the task. FDA’s 2026 clinical decision support guidance clarifies when AI functions may constitute regulated device software and what transparency, intended use, and human oversight requirements apply. ONC’s HTI-1 rule establishes algorithm transparency requirements for certified health IT. These aren’t theoretical considerations. They apply directly to how agentic workflows are designed, deployed, and audited.

In practice, governance means being able to answer basic questions after the fact: What data did the agent see? What action did it take? Which version ran? Who approved it? Organizations that cannot reconstruct a complete case trail will not be able to satisfy a compliance, legal, or clinical audit. That means role-based access, versioned instructions, immutable logs, exception capture, human approval boundaries, and a defined rollback path.

The organizations that succeed with AI agents won’t remove humans from the loop entirely. They will design systems where humans remain strategically involved while operational friction decreases around them. Healthcare does not need autonomous chaos. It needs governed augmentation.

Parameter #5: Are You Starting from a Measurable Outcome or an Undefined Objective?

Many healthcare organizations are pursuing AI agents because competitors are talking about them. That creates pressure to move without clearly defining what operational outcome the investment is supposed to improve.

The strongest healthcare AI initiatives start with a specific, measurable problem. Prior authorization costs the average physician practice the equivalent of 12 hours of staff time per week. Ambient AI tools reduced burnout prevalence by more than 21 percentage points in one Mass General Brigham study. Documentation-related well-being improved by more than 30% in another. These are the kinds of outcomes that justify investment and create the conditions for adoption, because they connect directly to what operational and clinical leaders already track.

The organizations that succeed with AI agents won’t necessarily be the first to deploy them. They will be the ones who implement them against specific, expensive, operationally painful workflows where the improvement can be measured within a planning cycle.

The Foundation Comes Before the Agent

Pegasus One works with healthcare organizations on exactly this sequence: Signal, Orchestration, Normalization, and Governance. As an artificial intelligence development company focused specifically on healthcare, Pegasus One’s work begins where most implementations fail: the infrastructure layer. The specific use cases, prior authorization, eligibility, care coordination, scheduling, and claims, aren’t chosen arbitrarily. They are the workflows where interoperability maturity, bounded autonomy, and measurable ROI align most clearly at the current state of the market. That is why foundational work matters so much right now.

FHIR-native interoperability, workflow mapping, structured data environments, real-time architectures, and governance frameworks are what allow an agent to operate safely inside a real clinical or administrative workflow. Without them, a pilot that works in a demo will fail in production because the data arrives late, the terminology does not normalize, the audit trail doesn’t exist, or the workflow boundary is unclear. These are the most common reasons implementations stall, not edge cases.

Agents will become the next UI in healthcare. The organizations that win won’t be the ones that deploy them fastest. They will be the ones who build environments where agents can operate safely, reliably, and intelligently inside real healthcare workflows.

Start with the Right Workflow

Pegasus One is a machine learning development company built for the specific demands of healthcare. That means helping organizations identify the one bounded workflow worth automating first, then building the interoperability, governance, and integration infrastructure to make it work in production. If you are evaluating where to start, that is the conversation to have before the implementation begins.